Retraction: Ke et al. Resveratrol enhances chemosensitivity of renal cell carcinoma to paclitaxel. Frontiers in Bioscience (Landmark Edition). 2019; 24: 1452–1461

Frontiers in Bioscience-Landmark Editorial Office

Open source

DOI
10.31083/fbl37283
Published
2025-01-20
Container
Frontiers in Bioscience-Landmark
Publisher
IMR Press
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.31083/fbl37283,
  title = {Retraction: Ke et al. Resveratrol enhances chemosensitivity of renal cell carcinoma to paclitaxel. Frontiers in Bioscience (Landmark Edition). 2019; 24: 1452–1461},
  author = {Frontiers in Bioscience-Landmark Editorial Office},
  year = {2025},
  journal = {Frontiers in Bioscience-Landmark},
  doi = {10.31083/fbl37283},
  url = {https://doi.org/10.31083/fbl37283}
}

RIS

TY  - JOUR
TI  - Retraction: Ke et al. Resveratrol enhances chemosensitivity of renal cell carcinoma to paclitaxel. Frontiers in Bioscience (Landmark Edition). 2019; 24: 1452–1461
AU  - Frontiers in Bioscience-Landmark Editorial Office
PY  - 2025
JO  - Frontiers in Bioscience-Landmark
DO  - 10.31083/fbl37283
UR  - https://doi.org/10.31083/fbl37283
ER  - 

APA

Office, F. I. B. E. (2025). Retraction: Ke et al. Resveratrol enhances chemosensitivity of renal cell carcinoma to paclitaxel. Frontiers in Bioscience (Landmark Edition). 2019; 24: 1452–1461. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl37283

Source records